Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) kicked off on Monday, down -6.72% from the previous trading day, before settling in for the closing price of $9.97. Over the past 52 weeks, ARCT has traded in a range of $8.04-$24.17.
Annual sales at Healthcare sector company slipped by -6.84% over the past five years. While this was happening, its average annual earnings per share was recorded 12.05%. With a float of $24.87 million, this company’s outstanding shares have now reached $27.15 million.
Arcturus Therapeutics Holdings Inc (ARCT) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Arcturus Therapeutics Holdings Inc is 8.42%, while institutional ownership is 95.98%.
Arcturus Therapeutics Holdings Inc (ARCT) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.26 earnings per share (EPS), higher than consensus estimate (set at -1.02) by 0.76. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.97 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 12.05% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 21.35% during the next five years compared to -6.84% drop over the previous five years of trading.
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) Trading Performance Indicators
Take a look at Arcturus Therapeutics Holdings Inc’s (ARCT) current performance indicators. Last quarter, stock had a quick ratio of 5.90. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.30.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.22, a number that is poised to hit -0.90 in the next quarter and is forecasted to reach -2.66 in one year’s time.
Technical Analysis of Arcturus Therapeutics Holdings Inc (ARCT)
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) saw its 5-day average volume 1.28 million, a positive change from its year-to-date volume of 0.67 million. As of the previous 9 days, the stock’s Stochastic %D was 3.97%.
During the past 100 days, Arcturus Therapeutics Holdings Inc’s (ARCT) raw stochastic average was set at 0.73%, which indicates a significant increase from 0.73% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.37 in the past 14 days, which was higher than the 1.24 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $17.79, while its 200-day Moving Average is $14.72. Nevertheless, the first resistance level for the watch stands at $9.87 in the near term. At $10.44, the stock is likely to face the second major resistance level. The third major resistance level sits at $10.76. If the price goes on to break the first support level at $8.98, it is likely to go to the next support level at $8.66. Assuming the price breaks the second support level, the third support level stands at $8.09.
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) Key Stats
The company with the Market Capitalisation of 252.54 million has total of 27,155K Shares Outstanding. Its annual sales at the moment are 152,310 K in contrast with the sum of -80,940 K annual income. Company’s last quarter sales were recorded 28,300 K and last quarter income was -9,180 K.
